down arrow

Adline Chem Lab

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE276T01018
  • NSEID:
  • BSEID: 524604
INR
9.40
-0.36 (-3.69%)
BSENSE

Apr 11, 11:29 AM

BSE+NSE Vol: 200

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Adline Chem Lab Ltd stock-summary
stock-summary
Adline Chem Lab Ltd
Micro Cap
Pharmaceuticals & Drugs
Adline Chem Lab Limited (Formerly known as Kamron Laboratories Limited) was incorporated in 1988 by its Promoter, Mr Kamlesh J Laskari. The Company name was changed from `Kamron Laboratories Limited' to Adline Chem Lab Limited effective on October 13, 2021. The Company is engaged primarily in the business of marketing of Pharmaceutical and Nutraceuticals products. In May 1990, the Company started production at its site in Rakanpur, Gujarat.
Company Coordinates stock-summary
Company Details
904 9th Floor, Shapath-I Complex S G Highway Ahmedabad Gujarat : 382721
stock-summary
Tel: 91-02764-286549/286559
stock-summary
info@kamronlabs.com
Registrar Details
Kamron Laboratories Ltd., 737 Rakanpur Village, Sola Santej Road, Ta. Kalol (N. G.), Gandhinagar
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Hemant Amrish Parikh (25.85%)

Highest Public shareholder

None

Individual Investors Holdings

60.15%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Mahendra P Shah
Chairman & Independent Directo
0
Kamlesh J Laskari
ED / MD / Promoter
0
Ranak K Laskari
Non Executive Director
0
Devarshi D Patel
Independent Non Exe. Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Pharmaceuticals Products
2.7014
0%
 
100
Pharmaceuticals Products
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2024)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 6 Cr (Micro Cap)

stock-summary
P/E

6.00

stock-summary
Industry P/E

24

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.84

stock-summary
Return on Equity

-10.50%

stock-summary
Price to Book

-3.33